Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pyrazole and pyrazoline derivatives as antimalarial agents: A key review
Lekkala Ravindar, Siti Aishah Hasbullah, K.P. Rakesh, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 183, pp. 106365-106365
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Triazole hybrid compounds: A new frontier in malaria treatment
Lekkala Ravindar, Siti Aishah Hasbullah, K.P. Rakesh, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115694-115694
Closed Access | Times Cited: 28
Recent developments in antimalarial activities of 4-aminoquinoline derivatives
Lekkala Ravindar, Siti Aishah Hasbullah, K.P. Rakesh, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115458-115458
Closed Access | Times Cited: 27
Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers
Zhi Xu, Yafei Zhuang, Qingtai Chen
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115495-115495
Closed Access | Times Cited: 24
Exploring the antimalarial and antioxidant efficacy of transition metal(II) chelates of thiosemicarbazone ligands: spectral investigations, molecular docking, DFT, MESP and ADMET
Jai Devi, Binesh Kumar, Amit Dubey, et al.
BioMetals (2023) Vol. 37, Iss. 1, pp. 247-265
Closed Access | Times Cited: 21
Triazole derivatives as potential antifungal agents: A structure-activity relationship (SAR) studies
Yuexiao Hu, Ziwei Liu, Gao‐Feng Zha, et al.
Process Biochemistry (2023) Vol. 135, pp. 102-118
Closed Access | Times Cited: 19
In silico and in vitro prediction of new synthesized N-heterocyclic compounds as anti-SARS-CoV-2
Heba E. Hashem, Sajjad Ahmad, Ajoy Kumer, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Emerging nanotechnology-driven drug delivery solutions for malaria: Addressing drug resistance and improving therapeutic success
Anuradha Mishra, Firdaus Qamar, Kudsiya Ashrafi, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125163-125163
Closed Access
Development of 1,2,3-triazole hybrids as multi-faced anticancer agents co-targeting EGFR/mTOR pathway and tubulin depolymerization
Mennatallah A. Shaheen, Khaled M. Darwish, Safaa M. Kishk, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108153-108153
Closed Access
Study of physiochemical properties of trisubstituted pyrazole derivatives using polar aprotic solvents
Poonam Devi, Hardeep Anand, Rashmi Pundeer, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Vanillin Derived Hydrazone Ligands and Their Transition Metal Complexes: Synthesis, Characterization, Biological Activity and Molecular Docking Studies
Jai Devi, Tanisha Arora
Journal of Inorganic and Organometallic Polymers and Materials (2025)
Closed Access
Design, synthesis and biological evaluation of new class of pyrazoles-dihydropyrimidinone derivatives as bone anabolic agents
Arvind Kumar Jaiswal, Anuj Raj, Ajay Kishor Kushawaha, et al.
Bioorganic Chemistry (2025), pp. 108216-108216
Closed Access
Exploring diverse frontiers: Advancements of bioactive 4-aminoquinoline-based molecular hybrids in targeted therapeutics and beyond
Lekkala Ravindar, Siti Aishah Hasbullah, K.P. Rakesh, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116043-116043
Closed Access | Times Cited: 17
Current development of β-carboline derived potential antimalarial scaffolds
Preeti Kushwaha, Vipin Kumar, Biswajit Saha
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115247-115247
Closed Access | Times Cited: 16
Pyrazole: an Emerging Privileged Scaffold in Drug Discovery
Mohammad A. Alam
Future Medicinal Chemistry (2023) Vol. 15, Iss. 21, pp. 2011-2023
Open Access | Times Cited: 16
Discovery of Pyrano[2,3-c]pyrazole Derivatives as Novel Potential Human Coronavirus Inhibitors: Design, Synthesis, In Silico, In Vitro, and ADME Studies
Abdou K. Allayeh, Aliaa H. El-boghdady, Mohamed A. Said, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 198-198
Open Access | Times Cited: 5
Strategies and Methods for the Synthesis of 2‐Pyrazolines: Recent Developments (2012–2022)
Dimitris Matiadis
Advanced Synthesis & Catalysis (2023) Vol. 365, Iss. 12, pp. 1934-1969
Open Access | Times Cited: 12
Novel Pyrazole-4-Carboxamide Derivatives Containing Oxime Ether Group as Potential SDHIs to Control Rhizoctonia solani
Bo Luo, Yuerui Wu, Xinran Ren, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 17, pp. 9599-9610
Closed Access | Times Cited: 3
Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors
Subrata Roy, Hansa Raj KC, Justin Roberts, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 19, pp. 13622-13645
Open Access | Times Cited: 10
Synthesis and anticancer activity of 3-(1-aryl-5-methyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazole-4-carbaldehydes
Bakr F. Abdel-Wahab, Benson M. Kariuki, Hanan A. Mohamed, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136528-136528
Open Access | Times Cited: 8
TCS/ZnCl2 as a controlled reagent for the Michael addition and heterocyclic cyclization based on the phenyl pyrazolone scaffold with docking validation as a Covid-19 protease inhibitor
Abdulrahman A. Almehizia, Ahmad M. Naglah, Amer Alhaj Zen, et al.
Bulletin of the Chemical Society of Ethiopia (2024) Vol. 38, Iss. 4, pp. 1119-1127
Open Access | Times Cited: 2
Exploring antimalarial potential: Conjugating organometallic moieties with organic fragments for enhanced efficacy
Nur Aqilah Zahirah Norazmi, Nur Hafizah Mukhtar, Lekkala Ravindar, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107510-107510
Closed Access | Times Cited: 2
Synthesis of ring fused difluoromethyl pyrazolines and pyrazoles by cycloaddition of difluoroacetohydrazonoyl bromides with cyclic α,β-Unsaturated carbonyl compounds
Yuanyuan Ren, Ransong Ma, Xiaoyong Li, et al.
Tetrahedron (2023) Vol. 149, pp. 133711-133711
Closed Access | Times Cited: 6
Structure–Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents
Matteo Lusardi, Maria Grazia Signorello, Eleonora Russo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4607-4607
Open Access | Times Cited: 1
Recent developments of P-glycoprotein inhibitors and its structure–activity relationship (SAR) studies
Xuanming Zhao, Jing Di, Dingjie Luo, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106997-106997
Closed Access | Times Cited: 5
Microwave accelerated green access to functionalized pyrazolo[5,1-b]quinazoline-3-carboxylate scaffold and their pharmacological screening
Reena C. Patel, Dhanji P. Rajani, Anju Kunjadiya, et al.
Journal of Molecular Structure (2024) Vol. 1310, pp. 138295-138295
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top